UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis

Liang Zhao1, Min Kang1, Xiaomeng Liu1

  • 1Department of Hepatobiliary Surgery and Oncology, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China.

Abstract

Insights

UBR7, a ubiquitin ligase, suppresses hepatocellular carcinoma (HCC) by inhibiting glycolysis. Loss of UBR7 promotes HCC, highlighting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Glycolysis is a key target for cancer therapy, especially for cancers with limited treatment options.
  • The ubiquitin-proteasome system, involving E3 ligases, regulates protein turnover.
  • UBR7, an understudied E3 ligase, plays a role in glycolysis and HCC tumorigenesis via histone modification.

Purpose of the Study:

  • To investigate the role of UBR7 in regulating glycolysis and hepatocellular carcinoma (HCC) progression.
  • To identify epigenetic regulators of lactic acid metabolism in HCC.

Main Methods:

  • High-throughput RNAi screening was employed to identify epigenetic candidates.
  • Investigated the mechanism of UBR7's regulation of glycolysis and HCC tumorigenesis.
  • Analyzed the impact of UBR7 on histone H2B monoubiquitination (H2BK120ub) and downstream signaling pathways.

Main Results:

  • UBR7 loss promotes HCC tumorigenesis in vitro and in vivo.
  • UBR7 inhibits glycolysis by suppressing HK2 expression via the Keap1/Nrf2/Bach1 axis.
  • UBR7 regulates H2BK120ub, affecting Keap1 expression and downstream signaling.
  • ALKBH5 regulates UBR7 expression in an m6A-dependent manner.

Conclusions:

  • UBR7 is a critical negative regulator of aerobic glycolysis and HCC tumorigenesis.
  • The UBR7-regulated Keap1/Nrf2/Bach1/HK2 axis is crucial for HCC progression.
  • UBR7 represents a potential therapeutic target for HCC treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K